Watch Ticker

Neurocrine Biosciences Inc

Go to Neurocrine Biosciences Inc Website

$127.75

-0.29 (-0.23%)
Live
Previous Close

$128.04

Day Range

$126.6 - $128.735

Previous Day Range

$125.37 - $128.91

Market Cap

$12.8 billion USD

Day Vol.

447099

Previous Day Vol.

1.5 million

Currency

USD

Primary Exchange

Nasdaq

Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive ...

Community
  • 0 posts discussing
0

Watchers

0

Visitors

Recent News

Neurocrine Biosciences reported strong Q2 2025 financial results, with revenue of $687.5 million, exceeding analyst expectations. The company saw significant growth from INGREZZA and a successful launch of CRENESSITY, while continuing to invest in its drug pipeline and research and development.

Related tickers: NBIX.

Read Full Article

Voyager Therapeutics expanded its Alzheimer's disease franchise by introducing a new gene therapy program targeting APOE, complementing existing tau and amyloid assets. The program aims to reduce APOE4 variant expression while delivering the protective APOE2 variant using an innovative IV-delivered TRACER capsid.

Related tickers: VYGR, AZN, NVS, NBIX.

Read Full Article
Trending Tickers

Please sign in to view